High Efficacy of Therapeutic Equine Hyperimmune Antibodies Against SARS-CoV-2 Variants of Concern

Bibliographic Details
Title: High Efficacy of Therapeutic Equine Hyperimmune Antibodies Against SARS-CoV-2 Variants of Concern
Authors: Andres Moreira-Soto, Mauricio Arguedas, Hebleen Brenes, Willem Buján, Eugenia Corrales-Aguilar, Cecilia Díaz, Ann Echeverri, Marietta Flores-Díaz, Aarón Gómez, Andrés Hernández, María Herrera, Guillermo León, Román Macaya, Arne Kühne, José Arturo Molina-Mora, Javier Mora, Alfredo Sanabria, Andrés Sánchez, Laura Sánchez, Álvaro Segura, Eduardo Segura, Daniela Solano, Claudio Soto, Jennifer L. Stynoski, Mariángela Vargas, Mauren Villalta, Chantal B. E. M. Reusken, Christian Drosten, José María Gutiérrez, Alberto Alape-Girón, Jan Felix Drexler
Source: Frontiers in Medicine, Vol 8 (2021)
Publisher Information: Frontiers Media S.A., 2021.
Publication Year: 2021
Collection: LCC:Medicine (General)
Subject Terms: equine antibodies, SARS-CoV-2, therapy, variant of concern, PRNT titers 50, neutralization test, Medicine (General), R5-920
More Details: SARS-CoV-2 variants of concern show reduced neutralization by vaccine-induced and therapeutic monoclonal antibodies; therefore, treatment alternatives are needed. We tested therapeutic equine polyclonal antibodies (pAbs) that are being assessed in clinical trials in Costa Rica against five globally circulating variants of concern: alpha, beta, epsilon, gamma and delta, using plaque reduction neutralization assays. We show that equine pAbs efficiently neutralize the variants of concern, with inhibitory concentrations in the range of 0.146–1.078 μg/mL, which correspond to extremely low concentrations when compared to pAbs doses used in clinical trials. Equine pAbs are an effective, broad coverage, low-cost and a scalable COVID-19 treatment.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2296-858X
Relation: https://www.frontiersin.org/articles/10.3389/fmed.2021.735853/full; https://doaj.org/toc/2296-858X
DOI: 10.3389/fmed.2021.735853
Access URL: https://doaj.org/article/5c7bd487a62f49e99fe55294c82b87f6
Accession Number: edsdoj.5c7bd487a62f49e99fe55294c82b87f6
Database: Directory of Open Access Journals
More Details
ISSN:2296858X
DOI:10.3389/fmed.2021.735853
Published in:Frontiers in Medicine
Language:English